Comparison
NMN vs Fisetin
NMN
Nicotinamide mononucleotide, NAD+ precursor. Studied for cellular aging and metabolic health.
Fisetin
Flavonoid found in strawberries. Senolytic, selectively clears senescent cells. Promising longevity intervention.
| Field | NMN | Fisetin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 100–500mg |
| Half-life | – | – |
| Onset | – | – |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 1700 |
The comparison in plain English
Auto-generated from dataNMN and Fisetin are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide, NAD+ precursor. Fisetin Flavonoid found in strawberries.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Fisetin (evidence B, safety 4/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+, one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is –h.
Choose Fisetin if
Fisetin is the better fit when your goal aligns with its mechanism (Senolytic activity, selectively induces apoptosis in senescent cells (cells that have stopped dividing but remain metabolically active and inflammatory)) and the dose range (100–500mg) suits your protocol. Half-life is –h.